Skip to main content

Catherine Bollard, MD

Washington, DC
United States

Children's Research Institute

Dr. Bollard received her medical degree at the University of Otago. She is board certified both in pediatrics and hematology. She is currently the Bosworth Chair for Cancer Biology, the Director of the Center for Cancer and Immunology Research, and the Director of the Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children’s National Health System. She is a Professor of Pediatrics and of Microbiology, Immunology, and Tropical Medicine at The George Washington University and the Associate Center Director for Translational Research and Innovation at the GW Cancer Center. Dr. Bollard is a member of the American Society for Clinical Investigation (ASCI) and is the current President of the Foundation for the Accreditation of Cellular Therapy (FACT). She is currently Editor in Chief of Blood Advances. She has over 200 peer reviewed publications. Her bench and translational research focuses on improving outcomes for patients after hematopoietic stem cell transplantation and on the development of novel cell therapies for cancer and virus-associated diseases.

Program Name(s)
Translational Research Program
Catherine Bollard